| __timestamp | Bausch Health Companies Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 16758000 |
| Thursday, January 1, 2015 | 2682700000 | 17793000 |
| Friday, January 1, 2016 | 2810000000 | 18761000 |
| Sunday, January 1, 2017 | 2582000000 | 19287000 |
| Monday, January 1, 2018 | 2473000000 | 18707000 |
| Tuesday, January 1, 2019 | 2554000000 | 20893000 |
| Wednesday, January 1, 2020 | 2367000000 | 25678000 |
| Friday, January 1, 2021 | 2624000000 | 29665000 |
| Saturday, January 1, 2022 | 2625000000 | 43628000 |
| Sunday, January 1, 2023 | 2917000000 | 69135000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding operational efficiency is crucial. Bausch Health Companies Inc. and Geron Corporation, two prominent players, offer a fascinating study in contrasts. Over the past decade, Bausch Health has consistently reported higher Selling, General, and Administrative (SG&A) expenses, peaking at nearly $2.9 billion in 2023. This represents a 44% increase from 2014, reflecting their expansive operational scale. In contrast, Geron Corporation's SG&A expenses, while significantly lower, have surged by over 300% during the same period, reaching approximately $69 million in 2023. This dramatic rise highlights Geron's strategic investments in growth and development. The data underscores the diverse strategies these companies employ to navigate the pharmaceutical industry's challenges, with Bausch focusing on maintaining its vast operations and Geron investing heavily in its future potential.
Sanofi and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Bausch Health Companies Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.